Patent classifications
A61K2236/11
Cordyceps Militaris Designated as Strain M2-105-04, Compositions, Methods of Making, Methods of Using and Methods for Treating Mammal
Exemplary embodiments include a whole mycelium of Cordyceps militaris designated as strain M2-105-04 as deposited with the ATCC Patent Depository under the Budapest Treaty (10801 University Blvd, Manassas, VA 20110), on Jul. 28, 2023, with the unofficial ATCC Patent Deposit Designation No. PTA-127612 and the official deposit date of Jul. 28, 2023 and the official patent deposit number of PTA-127612. The whole mycelium is characterized by a phenotype having an abundance of fruiting bodies on top of a substrate and/or along a parameter of a bioreactor bag. It is also characterized by a phenotype having fruiting initiation at or near 18 days after inoculation, a phenotype having fruiting bodies maturing at or near 55 days after inoculation, and/or a phenotype having a 10-to-15-day colonization time on hulled oats.
SKIN EXTERNAL COMPOSITION AND METHOD FOR PREPARING THE SAME
One aspect of the present disclosure is to a skin external composition and a method for preparing the same, and more particularly, the skin external composition includes a Pueraria thunbergiana honey water extract as an active ingredient to exhibit excellent anti-inflammatory and moisturizing effects.
INSECT AND CANNABIS PRODUCTION SYSTEMS AND METHODS
Variable-scale, modular, easily manufacturable, energy efficient, reliable, and computer operated Insect Production Superstructure Systems (IPSS) and Farming Superstructure Systems (FSS) may be used to produce cannabis, insects, and psilocybin mushrooms for human and animal consumption, and for the extraction and use of lipids, drugs, and chemicals for applications involving medicine, nanotechnology, consumer products, pharmaceuticals, pet food, and chemical production with minimal water, feedstock, and environmental impact.
Method of maximizing epigallocatechin gallate content in tea
This invention describes a new method to maximize the epigallocatechin gallate (EGCG) content of brewed tea made using leaves and buds from C. sinensis. Unlike conventional tea processing methods, the method of the invention aims to minimize the leaf withering step, the oxidation step and any heating steps, all of which are present in many conventional tea processing methods. The method of the invention treats minimally withered tea leaf and bud material with an acid treatment and then a maceration treatment, optionally freezing the acid-treated material for storage purposes. The brewed tea resulting from the acid-treated and macerated leaves has a significantly higher EGCG content than conventionally produced teas.
Process for the preparation of a raw material enriched with isothiocyanates and polyphenols
Disclosed is a process for the preparation of moringa (Moringa oleifera Lam.) sprouts by hydroponic cultivation from seed, as well as a process for the preparation of a raw material enriched with isothiocyanates and polyphenols, starting from moringa (Moringa oleifera Lam.) sprouts obtained from seed by the process and/or from the adult plant, and to the raw material obtained by the process.
EXTRACT OF UNDIFFERENTIATED CELLS OF MIMOSA PUDICA AND USES THEREOF IN DERMO-COSMETICS
The present invention relates to a preparation obtained from an in vitro culture of undifferentiated cells of Mimosa pudica, as well as to the preparation method thereof; a cosmetic or dermatological composition comprising said preparation; and the uses thereof for the treatment of inflammatory skin conditions, as an antioxidant agent in the treatment of oxidative stress caused by environmental pollution, and as an anti-aging agent.
METHOD FOR PRODUCING CELASTROL AND PENTACYCLIC TRITERPENE DERIVATIVES
The present invention relates to a method for producing a crude extract enriched in pentacyclic triterpenes, including celastrol, from cells of a plant from the Celastraceae family; an enriched crude extract that can be obtained using such a method; therapeutic applications of such an extract; and pharmaceutical and dermocosmetic compositions containing such an extract.
Method of microalgal biomass processing for high-value chemicals production, the resulting composition of butyrogenic algal slowly fermenting dietary fiber, and a way to improve colon health using a slowly fermenting butyrogenic algal dietary fiber
A method to process microalgae biomass and produce high-value chemicals from microalgae biomass is disclosed. The method uses the same biomass cells to extract more than one component such as are lipids, water-soluble chemicals, carotenoids, polysaccharides and algae meal. The method is a sequence of physical and chemical treatments. Water soluble polysaccharides produced by the method exhibit properties of low viscosity at low shear thinning. A method for extracting dietary fiber from microalgal biomass is disclosed. Compositions of water-soluble polysaccharides that are fermented slowly by colon microbiota with less gas production than commercial dietary fiber FOS are disclosed. The present inventions described herein provide a method of improving colon health by increasing butyrate during a microalgal dietary fiber fermenting process by colonic microbiota.
Salt-free miso production method, salt-free miso, hepatic function improvement agent, and hypertension improvement agent
Provided are: a production method for salt-free miso, in which steamed soy beans and koji are pressurized, heated, and fermented; salt-free miso obtained by said production method; and a hepatic function improvement agent and a hypertension improvement agent that contain said salt-free miso as an effective component thereof.
Method for inhibiting melanogenesis and promoting collagen production and wound healing
The present invention provides a method for inhibiting melanogenesis, promoting collagen production, and promoting wound healing in the skin of a subject in need thereof, comprising administering to the subject an effective amount of a compound represented by formula (I). The compound of the present invention can inhibit melanin formation, promote collagen production and facilitate wound repair. Therefore, the compound can be utilized to manufacture compositions for skin whitening, anti-aging, and wound healing. The present invention also provides a method of preparing a compound of formula (I).